<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Cationic antimicrobial peptide NRC-03 induces oral squamous cell carcinoma cell apoptosis via CypD-mPTP axis-mediated mitochondrial oxidative stress.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Cationic antimicrobial peptide NRC-03 induces oral squamous cell carcinoma cell apoptosis via CypD-mPTP axis-mediated mitochondrial oxidative stress." class="clickable-image" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511698/bin/gr3.jpg"/> </div> <div class="text-side"> <h1>Cationic antimicrobial peptide NRC-03 induces oral squamous cell carcinoma cell apoptosis via CypD-mPTP axis-mediated mitochondrial oxidative stress.</h1> <p>NRC-03 inhibited tumor growth in the ectopic tumor model of OSCC. CAL-27-derived xenografts were treated with 125 μg NRC-03 every other day for 15 days. (a) Gross images of representative tumor tissues on day 15. (b) Tumor volume at different time points (n = 6). (c) Final tumor volume on day 15 (n = 6). (d) Representative microscopic images of tumor tissue sections showing tumor morphology (H&amp;E staining), proliferation (Ki-67 immunohistochemistry), and apoptosis (TUNEL staining). Quantification of Ki-67-positive cells (e) (n = 6), and apoptotic cells (f) (n = 6). Data are presented as mean ± SD. Significant difference compared with the respective control group, ***p &lt; 0.001, and ****p &lt; 0.0001.</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35660629/" target="_blank">35660629</a></p><p>Type: Premalignant/Malignant, Category: Keratinocytic</p>
</div> </div></div></body></html>